Edwards Lifesciences Accumulated Retained Earnings Deficit Trend

EW -- USA Stock  

USD 153.90  1.03  0.67%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Accumulated Retained Earnings Deficit of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Shareholders Equity representing the cumulative amount of the entities undistributed earnings or deficit. May only be reported annually by certain companies, rather than quarterly.
Accumulated Retained Earnings Deficit10 Years Trend
Increasing
Slightly volatile
 Accumulated Retained Earnings Deficit 
      Timeline 

Regression Statistics

Arithmetic Mean  2,014,773,684
Geometric Mean  1,405,612,825
Coefficient Of Variation  68.79
Mean Deviation  1,191,633,198
Median  1,653,900,000
Standard Deviation  1,386,018,436
Range  3,818,600,000
R Value  0.98
R Squared  0.96
Significance  0.00000001
Slope  348,632,678

Edwards Lifesciences Accumulated Retained Earnings Deficit Over Time

2016-12-31  3,906,300,000 
2017-12-31  3,906,300,000 
2018-12-31  3,812,157,895 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Edwards Lifesciences Upcoming Company Events
Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.